Amibegron Hydrochloride

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAmibegron Hydrochloride
Drug Alias Name阿米贝隆amibegronum阿米勃隆SR-58611SR-58611A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[37] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorDepressive DisorderAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG